about
The RISAP-study: a complex intervention in risk communication and shared decision-making in general practiceRisk of cardiovascular disease? A qualitative study of risk interpretation among patients with high cholesterol.A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice--the ProCaRis study: study protocolPrevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.Speaking of risk, managing uncertainty: decision-making about cholesterol-reducing treatment in general practice.Interprofessional education about shared decision making for patients in primary care settings.Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.Waiting for diagnostic colonoscopy: a qualitative exploration of screening participants' experiences in a FIT-based colorectal cancer screening program.Developing a Self-Administered Decision Aid for Fecal Immunochemical Test–Based Colorectal Cancer Screening Tailored to Citizens With Lower Educational Attainment: Qualitative StudyHelpline Calling Patterns in a Colorectal Cancer Screening Program: A Cross-Sectional StudyMaking decisions about colorectal cancer screening. A qualitative study among citizens with lower educational attainmentA stitch in time saves nine: Perceptions about colorectal cancer screening after a non-cancer colonoscopy result. Qualitative studyGenetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes, and patient outcomesSurgical breast cancer patient pathway: Experiences of patients and relatives and their unmet needsThe effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial
P50
Q33699363-303E466D-D4F3-4ACF-B128-6C5875C640C2Q34990793-F0B53B76-D8F1-4FE4-8EA5-F80F41166788Q36730143-AB8CD8A5-8185-4685-8616-684FE8BCB075Q38919453-52783633-9F00-4AE4-B8F9-28FDF7B9252FQ39527709-F7AA973A-94DF-4344-9886-3F4D5590762AQ48565768-318928C2-A74F-4864-A499-077BF7E0230BQ49901202-45AEDCB5-02EA-4552-A3E5-EBF5EA5F3DCCQ55284572-AE92AFA6-0F4B-4E86-BBD3-9C9FC4209147Q60460146-98486C64-EB2F-4EE7-8291-470A126E873EQ60460223-CACB36C4-6543-4475-8D2A-BE6EB850A6D6Q60460266-DDC03B88-F1BC-4878-AFDD-0D55603E1C85Q63363894-5889692B-1C8E-4489-B876-0DE725F142C5Q63753726-35536DC1-E1BA-4E28-8468-6E7F386ACD2DQ63753732-8D8A2304-EC57-471A-A47A-EA49E81CECB2Q89594348-5AE9285F-58F5-4A04-816F-BB4100AD5ECA
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2099-253X
@en
name
Pia Kirkegaard
@ast
Pia Kirkegaard
@en
Pia Kirkegaard
@es
Pia Kirkegaard
@nl
type
label
Pia Kirkegaard
@ast
Pia Kirkegaard
@en
Pia Kirkegaard
@es
Pia Kirkegaard
@nl
prefLabel
Pia Kirkegaard
@ast
Pia Kirkegaard
@en
Pia Kirkegaard
@es
Pia Kirkegaard
@nl
P106
P21
P31
P496
0000-0003-2099-253X